You are here: Home / Public / News


Nano World Cancer Day 2018 (NWCD)
The 2018 edition of the Nano World Cancer Day will simultaneously take place in 10 countries on 2nd February 2018. Meet the experts in your country who are developing disruptive innovations based on Nanomedicine to beat cancer.
ENATRANS Webinars available on YouTube
Should you have missed all or one of the webinars on "Regulation of Nanomedicine", "the Nanomed Translation Hub" and "the NanomedTAB", check the recordings on YouTube:
ENATRANS Webinar - The Nanomedicine Translation Advisory Board (TAB) - on 15th december, 11:00 AM CEST
In the series of ENATRANS Webinars, this session on 15th december will address the nanomedTAB, a free of charge service offered by ENATRANS to European innovative projects in Nanomedicine at any stage of development.
ENATRANS Webinar - The regulation Ecosystem for Nanomedicine
ENATRANS organised this webinar on 1st december 2017 to inform about the regulation Ecosystem for Nanomedicine and to give practical advice about what is required and who can help at the different steps of the Nanomedicine regulation process. Recording of the webinar is available on YouTube.
Relive the Nanomed Award ceremony during BIO-Europe 2017 in Berlin
Videos of the Nanomed Award ceremony 2017 rewarding both LIFNano Therapeutics and Aerogelex for their outstanding innovations in the field of Nanomedicine are now available!
ESTHER Webinar, the Industrial Driven Initiative on Emerging and Strategic Technologies for Healthcare - on 6th December, 15:00 (CET)
The NMP TeAm project organises on 6th December at 15:00 (CET) a Virtual Event on the Industrial Driven Initiative on Emerging and Strategic Technologies for Healthcare (IDI ESTHER), for the area of Nanotechnologies, Advanced Materials, Biotechnology and Advanced Manufacturing and Processing (NMBP).
ENATRANS Webinar - The Nanomedicine Translation HUB - on 8th December, 10:00 AM CEST
The webinar will explain how the three elements of the Nanomedicine Translation HUB - Translation Advisory Board (TAB), Characterisation Laboratory (EUNCL) and GMP pilot lines - complement each other and how research groups and SMEs can access and benefit from their services.
Submit your pre-proposals for European Innovative Research & Technological Development Projects in Nanomedicine till January 16th, 2018 (17:00, CET)!
Nanomedicine Award 2017 - Recipients
The European Technology Platform on Nanomedicine (ETPN) and ENATRANS announced the 2 recipients of the Nanomedicine Award 2017
Open call for innovative projects in personalised healthcare
The EU-funded INNOLABS project will select more than 100 innovative project ideas to accelerate and further support both financially and with services. Final submission deadline: 30 September 2017.
Find Nanomedicine related videos on ENATRANS YouTube Channel
ENATRANS compiles videos, animated movies and recordings of inspiring talks in its YouTube Channel with a particular focus on Nanomedicine Translation.
6th Round of applications to the NanomedTAB is open
The Nanomedicine Translation Advisory Board (nanomedTAB) offers since 2015 a free-of-charge mentoring program to assess, advise and accelerate promising nanomedicine projects to the market, based on a team of top skills industry experts with diverse and complementary experience. The objective? Help all projects and teams to get to clinical and commercial application faster and more reliably.
Nanomedicine Translation around the globe - How to proper address regulatory processes for nanomedicines in different countries
Nanomedicine Award 2017: applications are now open!
The European Technology Platform for Nanomedicine (ETPN) and the EU-funded project ENATRANS, announce the launching of the 3rd edition of the Nanomedicine Award, which aims to promote and reward two excellent innovative nanomedicine-based solutions that could bring significant benefits to patients, answering thereby unmet medical needs. The winners in both categories will be announced and rewarded during the BIO-Europe conference in Berlin in November 2017. Apply Now!
First European Nanomed "Who's who"
The first "Who's who" dedicated to European SMEs in nanomedicine is about to go live!
EMA PRIME: an opportunity for the translation of Nanomedicine?
The European Medicines Agency (EMA) launched PRIME (PRIority MEdicines), a new scheme to enhance support for the development of medicines that target an unmet medical need. This voluntary scheme is based on enhanced interaction and early dialogue with developers of promising medicines, to optimise development plans and speed up evaluation so these medicines can reach patients earlier.
Interview of Dr. Klaus-Michael Weltring - Nanotechnology: a key to the future of medicine Interview
The COMPAMED Magazine interviewed the ENATRANS Partner Klaus-Michael Weltring to discuss about expectations, achievements, gaps and barriers for future medical products based on naotechnologies.
EU-NCL- First call for characterisation of injectable nanomedicines addressing cancer
The recently established European Nanomedicine Characterisation Laboratory (EU-NCL) aims at providing critical infrastructure and characterisation services that are needed to analyse physical and chemical attributes, in vitro biological properties, and in vivo characteristics of emerging nanomedicines ready for translation and clinical trials.
Filed under: